G/SPS/N/TPKM/303 Committee on Sanitary and Phytosanitary Measures NOTIFICATION Notifying Member: THE SEPARATE CUSTOMS TERRITORY OF TAIWAN, PENGHU, If applicable, name of local government involved: Agency responsible: Ministry of Health and Welfare Products covered (provide tariff item number(s) as specified in national schedules deposited with the WTO; ICS numbers should be provided in addition, where applicable): Livestock and poultry tissues Regions or countries likely to be affected, to the extent relevant or practicable: partners Specific regions or countries: Title of the notified document: Draft Standards for Veterinary Drug Residue Limits in
Foods Language(s): Chinese and English Number of pages: 14
http://members.wto.org/crnattachments/2014/SPS/CHT/14_0074_00_e.pdf http://members.wto.org/crnattachments/2014/SPS/CHT/14_0074_00_x.pdf
Description of content: Amendment to maximum residue limit for Amoxicillin, Ampicillin, Amprolium, Arsanilic acid, Benzylpenicillin, Procaine benzylpenicillin,
Bicozamycin, Cefuroxime, Chlortetracycline, Oxytetracycline, Tetracycline, Clopidol,
Cloxacillin, Diaveridine, Doxycycline, Ethopabate, Florfenicol, Flunixin, Hydrocortisone, Josamycin, Kanamycin, Lasalocid, Levamisole, Lincomycin, Maduramicin, Mebendazole,
Nosiheptide, Oleandomycin, Orbifloxacin, Oxolinic acid, Piperazine, Prednisolone,
Pyrantel, Pyrimethamine, Semduramicin, Spectinomycin, Spiramycin, Sulfamonomethoxine, Tiamulin and Trimethoprim.
Objective and rationale: [X] food safety, [ ] animal health, [ ] plant protection, [ ] protect humans from animal/plant pest or disease, [ ] protect territory from other damage from pests. Is there a relevant international standard? If so, identify the standard: Codex Alimentarius Commission (e.g. title or serial number of Codex standard or related text) World Organization for Animal Health (OIE) (e.g. Terrestrial or Aquatic Animal Health Code, chapter number) International Plant Protection Convention (e.g. ISPM number) Does this proposed regulation conform to the relevant international standard? [ ] Yes [ ] No If no, describe, whenever possible, how and why it deviates from the international standard: Other relevant documents and language(s) in which these are available: Draft Standards for Veterinary Drug Residue Limits in Foods (31 December 2013, Food
No. 1021351962) is available in English from the National Notification Authority,
National Enquiry Point, and Ministry of Health and Welfare. The amendment will be published in the Official Government Gazette when adopted. The full texts may be
downloaded from the following website: http://www.fda.gov.tw English
Proposed date of adoption (dd/mm/yy): To be determined. Proposed date of publication (dd/mm/yy): To be determined. Proposed date of entry into force: [ ] Six months from date of publication, and/or(dd/mm/yy): To be determined. Trade facilitating measure Final date for comments: [X] Sixty days from the date of circulation of the notification and/or (dd/mm/yy): 11 March 2014 Agency or authority designated to handle comments: [X] National Notification Authority, [X] National Enquiry Point. Address, fax number and e-mail address (if available) of other body:
Food and Drug Administration Ministry of Health and Welfare
No.161-2, Kunyang St., Nangang District, Taipei City 115-61, Taiwan (R.O.C.)
Fax: +(886 2) 2653 1062 E-mail: 1587syj@fda.gov.tw
Texts available from: [X] National Notification Authority, [X] National Enquiry Point. Address, fax number and e-mail address (if available) of other body:
Ministry of Health and Welfare No.161-2, Kunyang St., Nangang District, Taipei City 115-61, Taiwan (R.O.C.)
Patient Category Initial IV Therapy †‡ Oral Regimens (continue therapy for 60 days [IV and PO combined]) Patients should be treated with IV therapy initially. § or Treatment can be switched to oral therapy when clinically and Ciprofloxacin, 500 mg PO twice daily or Doxycycline, 100 mg PO twice daily One or two additional antimicrobials (agents with in v
Matthew R. Tidwell, APR Experience Morningstar Communications – Overland Park, KS Vice President Currently lead new business acquisition efforts and provide senior level client service for Morningstar Communications, a full-service marketing communications firm. Specialize in industries including healthcare, advanced energy, and financial services. Great Plains Energy / K